Roivant Sciences Stock Investor Sentiment

ROIV Stock  USD 11.13  0.02  0.18%   
Slightly above 62% of Roivant Sciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Roivant Sciences suggests that many traders are alarmed. Roivant Sciences' investing sentiment can be driven by a variety of factors including economic data, Roivant Sciences' earnings reports, geopolitical events, and overall market trends.
  
six days ago at www.macroaxis.com         
Acquisition by Vivek Ramaswamy of 13357857 shares of Roivant Sciences subject to Rule 16b-3
Macroaxis News
over a week ago at www.macroaxis.com         
Disposition of 100000 shares by Venker Eric of Roivant Sciences at 11.28 subject to Rule 16b-3
Macroaxis News
over a week ago at www.macroaxis.com         
Disposition of 11623 shares by Matthew Gline of Roivant Sciences at 11.15 subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Two Seas Capital LP Adjusts Position in Indivior PLC
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Roivant Sciences buys Immunovant Inc. shares and repurchases its own stock for 336.9 million each
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Is Roivant Sciences the Best Medical Stock to Buy Under 20?
Yahoo News
over three weeks ago at thelincolnianonline.com         
Annovis Bio versus Roivant Sciences Head to Head Review
news
over three weeks ago at news.google.com         
Roivant Sciences Ltd. Receives 17.93 Consensus Target Price from Analysts - MarketBeat
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
Why Roivant Sciences Ltd. Is Skyrocketing
Yahoo News
over three weeks ago at benzinga.com         
Strategic Sale Eric Venker Decides To Exercise Options Worth 3.86M At Roivant Sciences
benzinga news
over three weeks ago at thelincolnianonline.com         
Roivant Sciences Ltd. COO Sells 2,050,704.16 in Stock
news
over three weeks ago at news.google.com         
Roivant Sciences Ltd. COO Sells 2,050,704.16 in Stock - MarketBeat
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 177704 shares by Venker Eric of Roivant Sciences at 11.54 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 1896 shares by Richard Pulik of Roivant Sciences at 11.8 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 176900 shares by Venker Eric of Roivant Sciences at 11.82 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Roivant Sciences that are available to investors today. That information is available publicly through Roivant media outlets and privately through word of mouth or via Roivant internal channels. However, regardless of the origin, that massive amount of Roivant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Roivant Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Roivant Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Roivant Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Roivant Sciences alpha.

Roivant Sciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.